Traversa Therapeutics' Series B Round

Traversa Therapeutics raised a round of funding on April 23, 2009.

Traversa Therapeutics is a biopharmaceutical company engaged in the discovery, development and commercialization of RNAi anti-cancer therapeutics. The company strives to rapidly advance short interfe…

Articles about Traversa Therapeutics' Series B Round: